Icon’s second-quarter sales increase by 2% to €172m

ICON Plc, Ireland’s largest provider of clinical research for drugmakers, has said that second-quarter net sales rose 2% to $224 million (€172.3m).

Net revenues for the quarter were $224m, representing a 2% increase over net revenues of $220m for the same quarter last year.

On a constant currency basis revenue grew by 3.1%. Year-to-date, net revenues were $443m, representing a 1% increase over the same period last year.